Literature DB >> 25142459

Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms.

Troels S Jensen1, Nanna B Finnerup2.   

Abstract

Allodynia (pain due to a stimulus that does not usually provoke pain) and hyperalgesia (increased pain from a stimulus that usually provokes pain) are prominent symptoms in patients with neuropathic pain. Both are seen in various peripheral neuropathies and central pain disorders, and affect 15-50% of patients with neuropathic pain. Allodynia and hyperalgesia are classified according to the sensory modality (touch, pressure, pinprick, cold, and heat) that is used to elicit the sensation. Peripheral sensitisation and maladaptive central changes contribute to the generation and maintenance of these reactions, with separate mechanisms in different subtypes of allodynia and hyperalgesia. Pain intensity and relief are important measures in clinical pain studies, but might be insufficient to capture the complexity of the pain experience. Better understanding of allodynia and hyperalgesia might provide clues to the underlying pathophysiology of neuropathic pain and, as such, they represent new or additional endpoints in pain trials.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25142459     DOI: 10.1016/S1474-4422(14)70102-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  176 in total

1.  Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.

Authors:  Lindsay B Conner; Pedro Alvarez; Oliver Bogen; Jon D Levine
Journal:  J Pain       Date:  2015-12-22       Impact factor: 5.820

2.  Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.

Authors:  V Blair Journigan; Zhiwei Feng; Saifur Rahman; Yuanqiang Wang; A R M Ruhul Amin; Colleen E Heffner; Nicholas Bachtel; Siyi Wang; Sara Gonzalez-Rodriguez; Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Jacob K Hilton; Wade D Van Horn; Antonio Ferrer-Montiel; Xiang-Qun Xie; Taufiq Rahman
Journal:  ACS Chem Neurosci       Date:  2020-01-09       Impact factor: 4.418

3.  Functional Organization of Cutaneous and Muscle Afferent Synapses onto Immature Spinal Lamina I Projection Neurons.

Authors:  Jie Li; Mark L Baccei
Journal:  J Neurosci       Date:  2017-01-09       Impact factor: 6.167

4.  PI3K/Akt Pathway is Required for Spinal Central Sensitization in Neuropathic Pain.

Authors:  Wei Liu; Yanling Lv; Facheng Ren
Journal:  Cell Mol Neurobiol       Date:  2017-08-28       Impact factor: 5.046

5.  The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia.

Authors:  Muhammad Shahid; Fazal Subhan; Nazar Ul Islam; Nisar Ahmad; Umar Farooq; Sudhair Abbas; Shehla Akbar; Ihsan Ullah; Naila Raziq; Zia Ud Din
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-20       Impact factor: 3.000

6.  GT1b functions as a novel endogenous agonist of toll-like receptor 2 inducing neuropathic pain.

Authors:  Hyoungsub Lim; Jaesung Lee; Byunghyun You; Jae Hoon Oh; Hyuck Jun Mok; Yoo Sung Kim; Bo-Eun Yoon; Byung Gon Kim; Seung Keun Back; Jong-Sang Park; Kwang Pyo Kim; Ronald L Schnaar; Sung Joong Lee
Journal:  EMBO J       Date:  2020-02-06       Impact factor: 11.598

Review 7.  New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

Authors:  Eva L Feldman; Klaus-Armin Nave; Troels S Jensen; David L H Bennett
Journal:  Neuron       Date:  2017-03-22       Impact factor: 17.173

8.  Neuroprotective and antinociceptive effects of rosemary (Rosmarinus officinalis L.) extract in rats with painful diabetic neuropathy.

Authors:  Bahram Rasoulian; Zahra Hajializadeh; Saeed Esmaeili-Mahani; Marzieh Rashidipour; Iman Fatemi; Ayat Kaeidi
Journal:  J Physiol Sci       Date:  2018-05-12       Impact factor: 2.781

Review 9.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

10.  Characterizing pinprick-evoked brain potentials before and after experimentally induced secondary hyperalgesia.

Authors:  Emanuel N van den Broeke; André Mouraux; Antonia H Groneberg; Doreen B Pfau; Rolf-Detlef Treede; Thomas Klein
Journal:  J Neurophysiol       Date:  2015-09-02       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.